Northern Trust’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-348,282
| Closed | -$2.04M | – | 4360 |
|
|
2019
Q1 | $2.04M | Sell |
348,282
-18,700
| -5% | -$63.7K | ﹤0.01% | 3074 |
|
|
2018
Q4 | $477K | Buy |
366,982
+4,679
| +1% | +$8.13K | ﹤0.01% | 3560 |
|
|
2018
Q3 | $1.25M | Buy |
362,303
+4,423
| +1% | +$16.6K | ﹤0.01% | 3410 |
|
|
2018
Q2 | $1.63M | Buy |
357,880
+35,439
| +11% | +$141K | ﹤0.01% | 3302 |
|
|
2018
Q1 | $1.06M | Buy |
322,441
+197
| +0.1% | +$697 | ﹤0.01% | 3361 |
|
|
2017
Q4 | $1.26M | Buy |
322,244
+145,182
| +82% | +$791K | ﹤0.01% | 3340 |
|
|
2017
Q3 | $1.83M | Sell |
177,062
-3,815
| -2% | -$37.5K | ﹤0.01% | 3233 |
|
|
2017
Q2 | $1.76M | Buy |
180,877
+44,653
| +33% | +$313K | ﹤0.01% | 3243 |
|
|
2017
Q1 | $926K | Buy |
136,224
+9,526
| +8% | +$55.1K | ﹤0.01% | 3369 |
|
|
2016
Q4 | $697K | Buy |
126,698
+6,479
| +5% | +$45.8K | ﹤0.01% | 3444 |
|
|
2016
Q3 | $911K | Sell |
120,219
-6,429
| -5% | -$47K | ﹤0.01% | 3370 |
|
|
2016
Q2 | $1.03M | Sell |
126,648
-10,405
| -8% | -$130K | ﹤0.01% | 3338 |
|
|
2016
Q1 | $1.78M | Sell |
137,053
-143
| -0.1% | -$1.65K | ﹤0.01% | 3053 |
|
|
2015
Q4 | $2.75M | Buy |
137,196
+16,042
| +13% | +$276K | ﹤0.01% | 2859 |
|
|
2015
Q3 | $1.48M | Buy |
121,154
+33,558
| +38% | +$629K | ﹤0.01% | 3183 |
|
|
2015
Q2 | $1.81M | Buy |
87,596
+25,755
| +42% | +$608K | ﹤0.01% | 3112 |
|
|
2015
Q1 | $1.3M | Buy |
61,841
+7,270
| +13% | +$190K | ﹤0.01% | 3319 |
|
|
2014
Q4 | $1.68M | Buy |
+54,571
| New | +$1.52M | ﹤0.01% | 3205 |
|
Northern Trust's IMDZ Position: Q2 2019 in Review
Northern Trust sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 348,282 shares — an estimated $2.04M sold.
Northern Trust first reported a position in IMDZ in Q4 2014 and held it in 18 quarters. The position peaked at $2.75M in Q4 2015. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- Northern Trust reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- Northern Trust sold 348,282 Immune Design Corp. shares in Q2 2019, an estimated $2.04M.
- Northern Trust first reported a position in Immune Design Corp. in Q4 2014 and held it in 18 quarters.
- Northern Trust's Immune Design Corp. position peaked at $2.75M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on Northern Trust's 13F filing for Q2 2019, filed 13 Aug 2019.